SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051711
Filing Date
2020-11-06
Accepted
2020-11-06 09:38:52
Documents
70
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elox-10q_20200930.htm   iXBRL 10-Q 2385361
2 EX-31.1 elox-ex311_8.htm EX-31.1 8743
3 EX-31.2 elox-ex312_6.htm EX-31.2 9301
4 EX-32.1 elox-ex321_9.htm EX-32.1 6927
5 EX-32.2 elox-ex322_7.htm EX-32.2 6879
  Complete submission text file 0001564590-20-051711.txt   7193629

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA elox-20200930.xsd EX-101.SCH 47714
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elox-20200930_cal.xml EX-101.CAL 52243
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elox-20200930_def.xml EX-101.DEF 109172
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20200930_lab.xml EX-101.LAB 354584
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20200930_pre.xml EX-101.PRE 255142
11 EXTRACTED XBRL INSTANCE DOCUMENT elox-10q_20200930_htm.xml XML 1208591
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 201292735
SIC: 8731 Services-Commercial Physical & Biological Research